A case of refractory thrombotic thrombocytopenic purpura treated with plasmapheresis and rituximab

Please use this identifier to cite or link to this item: http://ir.mu.ac.ke:8080/jspui/handle/123456789/7819

Full metadata record

DC Field	Value	Language
dc.contributor.author	Kirui, N	-
dc.contributor.author	Sokwala, A	-
dc.date.accessioned	2023-07-18T08:38:15Z	-
dc.date.available	2023-07-18T08:38:15Z	-
dc.date.issued	2016-03-17	-
dc.identifier.uri	http://ir.mu.ac.ke:8080/jspui/handle/123456789/7819	-
dc.description.abstract	Thrombotic thrombocytopenic purpura (TTP) is a rare, life-threatening disorder with no prevalence or incidence studies in sub-Saharan Africa. Acquired TTP has several causes, all of which lead to decreased activity of von Willebrand factor cleaving protease (ADAMTS13) due to autoantibodies that are directed towards ADAMTS13. We report a case of a 46-year-old man who presented with most of the classic clinical manifestations of TTP.	en_US
dc.language.iso	en	en_US
dc.publisher	SAMJ	en_US
dc.subject	Thrombotic thrombocytopenic purpura	en_US
dc.subject	Life-threatening disorder	en_US
dc.title	A case of refractory thrombotic thrombocytopenic purpura treated with plasmapheresis and rituximab	en_US
dc.type	Article	en_US
Appears in Collections:	School of Medicine

Files in This Item:

File	Description	Size	Format
NICHOLAS.pdf		121.81 kB	Adobe PDF	View/Open